Treatment with gabapentin of 11 dogs with refractory idiopathic epilepsy

Veterinary Record

Volumn 159, Issue 26, 2006, Pages 881-884

  Platt, S R ^a   Adams, V ^a   Garosi, L S ^a,c   Abramson, C J ^b,e   Penderis, J ^a,d   De Stefani, A ^a   Matiasek, L ^a  

^a ANIMAL HEALTH TRUST   (United Kingdom)

^b OHIO STATE UNIVERSITY   (United States)

^c DAVIES VETERINARY SPECIALISTS   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e GULF COAST VETERINARY SPECIALISTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; PHENOBARBITAL; POTASSIUM BROMIDE;

ARTICLE; ATAXIA; DISEASE CONTROL; DISEASE DURATION; DOG DISEASE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; EPILEPSY; FEMALE; IDIOPATHIC DISEASE; LONG TERM CARE; LOW DRUG DOSE; MALE; NONHUMAN; SEDATION; TONIC CLONIC SEIZURE;

AMINES; ANIMALS; ANTICONVULSANTS; CYCLOHEXANECARBOXYLIC ACIDS; DOG DISEASES; DOGS; EPILEPSY; FEMALE; GAMMA-AMINOBUTYRIC ACID; MALE; SEIZURES; TREATMENT OUTCOME;

CANIS FAMILIARIS;

EID: 33846333471     PISSN: 00424900     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. ADUSUMALLI, V. E., GILCHRIST, J. R.,WICHMANN, J. K., KUCHARCZYK, N. & SOFIA, R. D. (1992) Pharmacokinetics of felbamate in pediatric and adult beagle dogs. Epilepsia 33, 955-960
2. BAULAC, M., CAVALCANTI, D., SEMAH, F., ARZIMANOGLOU, A. & PORTAL, J J. (1998) Gabapentin add-on therapy with adaptable dosages in 610 patients with partial epilepsy: an open, observational Study. The French Gabapentin Collaborative Group. Seizure 7, 55-62
3. BAYER, K.,AHMADI, S. & ZEILHOFER, H. U. (2004) Gabapentin may inhibit synaptic transmission in the mouse spinal cord dorsal horn through a preferential block of P/Q-type Ca2+ channels. Neuropharmacology 46, 743-749
4. CHADWICK, D., LEIDERMAN, D. B., SAUERMANN, W., ALEXANDER, J. & GAROFALO, E. (1996) Gabapentin in generalized seizures. Epilepsy Research 25,191-197
5. CRAMER, J. A., FISHER, R. S. & BEN-MENACHEM, E. (1999) New antiepileptic drugs: a comparison of key clinical trials. Epilepsia 40, 590-600
6. CZAPINSKI P, BLASZCZYK, B. & CZUCZWAR, S. J. (2005) Mechanisms of action of antiepileptic drugs. Current Topics in Medical Chemistry 5,3-14
7. DEWEY, C. W, GUILIANO, R., BOOTHE, D. M., BERG, J. M., KORTZ, G. D., JOSEPH, R. J. & BUDSBERG, S. C. (2004) Zonisamide therapy for refractory idiopathic epilepsy in dogs. Journal of the American Animal Hospital Association 40,285-291
8. FARNBACH, G. C. (1984) Serum concentrations and efficacy of phenytoin, phenobarbital, and primidone in canine epilepsy. Journal of the American Veterinary Medical Association 184, 1117-1120
9. HACHAD, H., RAGUENEAU-MAJLESSI I. & LEVY, R. H. (2002) New antiepileptic drugs: review on drug interactions. Therapeutic Drug Monitoring 24,91-103
10. HILLER, A., NGUYEN, N., STRASSBURG, C. P., LI, Q., JAINTA, H., PECHSTEIN, B,, RUUS, P, ENGEL, J., TUKEY, R. H. & KRONBACK, T. (1999) Retigabine N-glucuronidation and its potential role in enterohepatic circulation. Drug Metabolism and Disposition 27, 605-612
11. HUSSEIN, G., TROUPIN, A. S. & MONTOURIS, G. (1996) Gabapentin interaction with felbamate. Neurology 47, 1106
12. ISOHERRANEN, N., YAGEN, B., SOBACK, S., ROEDER, M., SCHURIG, V. & BIALER, M. (2001) Pharmacokinetics of levetiracetam and its enantiomer (R)-alplia-ethyl-2-oxo-pyrrolidine acetamide in dogs. Epilepsia 42, 825-830
13. JENSEN, A. A., MOSBACHER, J., ELG, S., LINGENHOEHL, K., LOHMANN, T., JOHANSEN, T. N., ABRAHAMSEN, B., MATTSSON, J. P, LEHMANN, A., BETTLER, B. & BRAUNER-OSBORNE, H. (2002) The anticonvulsant gabapentin (neurontin) does not act through gamma-aminobutyric acid-B receptors. Molecular Pharmacology 61, 1377-1384
14. KOESTER, L. S., BERTUOL, J. B., GROCH, K. R.,XAVIER, C. R., NIOELLERKE, R., MAYORGA, P., DALLA COSTA, T. & BASSANI,V. L. (2004) Bioavailability of carbamazepine: beta-cyclodextrin complex in beagle dogs from hydroxypropylmethylcellulose matrix tablets. European Journal of Pharmacological Science 22, 201-207
15. LAROCHE, S. M. & HELMERS, S. L. (2004) The new antiepileptic drugs: scienfific review. Journal of the American Medical Association 291, 605-614
16. MCDONALD, D. G., NAJAM Y., KEEGAN, M. B.,WHOOLEY, M., MADDEN, D. & MCMENAMIN, J. B. (2005) The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood. Seizure 14,112-116
17. MARCH, P. A., PODELL, M. & SAMS, R. A. (2002) Pharinacokinetics and toxicity of bromide following high-dose oral potassium bromide administration in healthy Beagles. Journal of Veterinary Pharmacology and Therapeutics 25,425-432
18. MATAR, K. M., NICHOLLS, P. J., BAWAZIR, S. A., AL-HASSAN, M. I. & TEKLE, A. (2000) Effect of vigabatrin and gabapentin on phenytoin pharmacokinctics in the dog. Pharmacology Research 42, 517-521
19. NG, G. Y., BERTRAND, S., SULLIVAN, R., ETHIER, N., WANG, J., YERGEY, J., BELLEY, M., TRIMBLE, L., BATEMAN, K., ALDER, L., SMITH, A., MCKERNAN, R., METTERS, K., O'NEILL, G. P., LACAILLE, J. C. & HERBERT, T. E. (2001) Gamma-aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action. Molecular Pharmacology 59,144-152
20. PETROFF, O. A., ROTHMAN, D. L., BEHAR, K. L., LAMOUREUX, D. & MATTSON, R. H. (1996) The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy. Annals of Neurology 39, 95-99
21. PODELL, M. (1998) Antiepileptic drug therapy. Clinical Techniques in Small Animal Practice 13, 185-192
22. PODELL, M. & FENNER, W. R. (1993) Bromide therapy in refractory canine idiopathic epilepsy. Journal of Veterinary Internal Medicine 7, 318-327
23. RADULOVIC, L. L., TURCK, D., VON HODENBERG, A., VOLLMER, K. O., MCNALLY, W P., DEHART, P. D., HANSON, B. J., BOCKBRADER, H. N. & CHANG, T. (1995) Disposition of gabapentin (neurontin) in mice, rats, dogs and monkeys. Drug Metabolism and Disposition 23, 441-448
24. RUEHLMANN, D., PODELL, M. & MARCH, P. (2001) Treatment of partial seizures and seizure-like activity with felbamate in six dogs. Journal of Small Animal Practice 42, 403-408
25. RUSTEMBEGOVIC, A., SOFIC, E., TAHIROVIC, I. & KUNDUROVIC, Z. (2004) A study of gabapentin in the treatment of tonic-clonic seizures of alcohol withdrawal syndrome. Medicinski Archiv 58, 5-6
26. SCHMIDT, D. (1991) Medical intractability in partial epilepsies. In Epilepsy Surgery. Ed H. Luders. New York, Raven Press. pp 83-90
27. SCHWARTZ-PORSCHE, D., LOSCHER,W. & FREY H. H. (1985) Therapeutic efficacy of phenobarbital and primidone in canine epilepsy: a comparison. Journal of Veterinary Pharmacology and Therapeutics 8, 113-119
28. SPECIALE, J., DAYRELL-HART, B. & STEINBERG, S.A. (1991) Clinical evaluation of gamma-vinyl-gamrna-aminobutyric acid for control of epilepsy in dogs. Journal of the American Veterinary Medical Association 198, 995-1000
29. STEINBERG, M. & FAISSLER, D. (2004) Levetiracetam therapy for long-term idiopathic epileptic dogs. Proceedings of the 22nd Annual American College of Veterinary Internal Medicine Forum. Minneapolis, USA, June 9 to 12,2004. p 818
30. VOLLMER, K. O., VON HODENBERG, A. & KOLLE, E. U. (1986) Pharmacokinetics and metabolism of gabapentin in rat, dog and man. Drug Research 36, 830-839
31. WILSON, E. A., SILLS, G. J., FORREST, G. & BRODIE, M. J. (1998) High dose gabapentin in refractory partial epilepsy: clinical observations in 50 patients. Epilepsy Research 29, 161-166